Tag Archives: CEO Jim Greenwood

Delivering on Biotech’s Promise to Treat Anthrax, Smallpox, Ebola

Jim Greenwood

Thanks to federal biodefense programs that partner with industry to develop and stockpile medical countermeasures, each year America is better equipped to respond to potential biological, chemical, nuclear and radiological threats, BIO president and CEO Jim Greenwood says in a Roll Call op-ed published today. With recent anthrax and smallpox incidents at CDC and NIH labs,  which fortunately did not lead to any human exposure,  it’s worth taking a look at how we might respond Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

President Obama Endorses Ag Biotech

Obama

In an April 11 letter to Julie Borlaug, President Obama wrote about how pleased he was to join in the celebration of her grandfather, Norman Borlaug, and his life and passion for feeding the hungry through biotechnology. Through ag biotech, Norman Borlaug, known as the “Father of the Green Revolution,” made it his life’s work to eradicate world hunger and was recently recognized posthumously for his contributions to the field. Sara Wyant of Agri-Pulse highlighted President’s Obama’s remarks to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO and Biominas Brasil to Co-Host 2014 BIO Latin America Conference

Jim Greenwood

I am excited to announce that BIO will co-host a new conference event, BIO Latin America, taking place September 9-11, 2014, in Rio de Janeiro, Brazil.  We recently entered into an agreement with Biominas Brasil, a not-for- profit institution dedicated to life sciences in the region, to build on the successful BioPartnering Latin America event held by Biominas the past four years.  This new international conference for BIO will complement our global portfolio of industry events. The decision Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biotech Investors, Emerging Companies Bullish On 2014

Jim Greenwood

The 16th BIO CEO & Investor Conference is off to a great start. This event has truly grown into a must attend for emerging companies and investors. This year, we have more than 1,300 participants, including more than 850 investors. In addition, we have helped to set up more than 1,700 partnering meetings for participants over the course of the conference. Our world-class partnering system, and the opportunity to hear from key industry leaders, is Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

Congress Passes Omnibus Spending Agreement

Jim Greenwood

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill for fiscal 2014, which would, among other things, allow the Food and Drug Administration (FDA) to access $85 million in user fees sequestered in 2013. In addition, BIO supports the agreement’s overall funding for: FDA, NIH, the biodefense enterprise; and improved program oversight of the important 340B program.  BIO also strongly supports the language in the bill providing the Department Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,